Comparison of the PROMIS Preference Score (PROPr) and EQ-5D-5L Index Value in General Population Samples in the United Kingdom, France, and Germany

May 1, 2022, 00:00 AM
10.1016/j.jval.2021.10.012
https://www.valueinhealthjournal.com/article/S1098-3015(21)03174-0/fulltext
Section Title : PATIENT-REPORTED OUTCOMES
Section Order : 824
First Page : 824

Objectives

The Patient-Reported Outcome Measurement Information System (PROMIS) Preference score (PROPr) can be used to assess health state utility (HSU) and estimate quality-adjusted life-years in cost-effectiveness analyses. It is based on item response theory and promises to overcome limitations of existing HSU scores such as ceiling effects. The PROPr contains 7 PROMIS domains: cognitive abilities, depression, fatigue, pain, physical function, sleep disturbance, and ability to participate in social roles and activities. We aimed to compare the PROPr with the 5-level EQ-5D (EQ-5D-5L) in terms of psychometric properties using data from 3 countries.

Methods

We collected PROMIS-29 profile and EQ-5D-5L data from 3 general population samples (United Kingdom = 1509, France = 1501, Germany = 1502). Given that cognition is not assessed by the PROMIS-29, it was predicted by the recommended linear regression model. We compared the convergent validity, known-groups construct validity, and ceiling and floor effects of the PROPr and EQ-5D-5L.

Results

The mean PROPr (0.48, 0.53, 0.48; P.01) across all samples. The differences were invariant to sex, income, occupation, education, and most conditions but not for age. The Pearson correlation coefficients between both scores were r = 0.74, r = 0.69, and r = 0.72. PROPr’s ceiling and floor effects both were minor to moderate. The EQ-5D-5L’s ceiling (floor) effects were major (negligible).

Conclusions

Both the EQ-5D-5L and the PROPr assessed by the PROMIS-29 show high validity. The PROPr yields considerably lower HSU values than the EQ-5D-5L. Consequences for quality-adjusted life-year measurements should be investigated in future research.

https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)03174-0&doi=10.1016/j.jval.2021.10.012
HEOR Topics :
  • Instrument Development, Validation, & Translation
  • Patient-Centered Research
  • Patient-reported Outcomes & Quality of Life Outcomes
  • Study Approaches
  • Surveys & Expert Panels
Tags :
  • EQ-5D
  • health-related quality of life
  • incremental cost-effectiveness ratio
  • outcome measures
  • Patient-Reported Outcome Measurement Information System Preference score
  • patient-reported outcomes
  • quality-adjusted life-year
Regions :
  • North America